← Back to patent-cliff list
CAS 50609-01-3
4-(2-(pyrrolidin-1-yl)ethoxy)aniline
Codes：FEDR-004
Application context (from source-drug indications)
骨髓纤维化Fedratinib脾大Fedratinib原发性血小板增多症Fedratinib真性红细胞增多症Fedratinib骨髓增生性疾病Fedratinib骨髓增生异常综合征Fedratinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| FedratinibFedratinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-bromo-N-(tert-butyl)benzenesulfonamide→2-chloro-5-methylpyrimidin-4-amine→N-(tert-butyl)-3-((2-chloro-5-methylpyrimidin-4-yl)amino)benzenesulfonamide→4-(2-(pyrrolidin-1-yl)ethoxy)aniline
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.